Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Quest Pharmatech Inc
V.QPT
Alternate Symbol(s):
QPTFF
Healthcare
Biotechnology
Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest...
Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:QPT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 07, 2021 6:16pm
RE:RE:RE:RE:RE:update ...
https://www.reuters.com/companies/078590.KQ https://www.reuters.com/companies/QPT.V Are we in the wrong stock? Is OQP really paying QPT? Almost feel like its the other way around :) -jokes aside
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Jan 07, 2021 4:36pm
RE:RE:RE:RE:update ...
To date, volume suggests that not many holders are running for the hills yet. OncoQuest will have money or at least equity from OQP which means that if the assets are not liquidated and and Phase III
...more
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(3)
•••
PosNeg1
X
View Profile
View Bullboard History
Comment by
PosNeg1
on Jan 07, 2021 9:01am
RE:RE:RE:update ...
One month delay on Dec 31st $ and 6 month extension on balance, which can close sooner and likely will. SP drop probably as agreed shareholders left trying to figure out what the value is on a per
...more
(52)
•••
Wapiti1000
X
View Profile
View Bullboard History
Comment by
Wapiti1000
on Jan 06, 2021 8:03am
RE:RE:update ...
Great summary, Koreans private Corp spinoff only ones gonna make any cash here. This will drop quick once shareholders catch on, way to complicated for amateur investors
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jan 06, 2021 7:47am
RE:update ...
The bottom line: What's changed is that QPT: TSX-V now owns directly (once shares of "OQP" are distributed to OncoQuest shareholders) assets, in the form of a number of shares
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jan 06, 2021 12:16am
update ...
https://www.newswire.ca/news-releases/quest-provides-update-to-immunotherapy-asset-transfer-between-oncoquest-inc-and-oncoquest-pharmaceuticals-inc--871706182.html
(3)
•••
PosNeg1
X
View Profile
View Bullboard History
Comment by
PosNeg1
on Dec 18, 2020 7:16am
RE:RE:RE:how long is the P3 trial?
Study completion 2024 -progression free survival up to 4 years. I think they'd submit with any good progression free survival rates of even 1 year. Investigator Assessed Progression Free Survival
...more
(52)
•••
Wapiti1000
X
View Profile
View Bullboard History
Comment by
Wapiti1000
on Dec 17, 2020 10:30am
RE:RE:how long is the P3 trial?
2027! Wow, long hold here folks, gl
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Dec 17, 2020 9:23am
RE:RE:how long is the P3 trial?
https://clinicaltrials.gov/ct2/show/NCT04498117 Estimated Primary Completion Date: June 26, 2024 Estimated Study date August 26, 2027 G1945V
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Dec 16, 2020 7:49pm
New CMO at OncoQuest ...
Just a recent update to add here ... https://www.pharmalive.com/new-chief-medical-officer-for-oncoquest-pharmaceuticals/
(5)
•••
Toorby
X
View Profile
View Bullboard History
Comment by
Toorby
on Dec 16, 2020 5:09pm
RE:how long is the P3 trial?
Funny you asked. I checked the site in the the last nr earlier today. It says completion date 2027 (not kidding) but usually that doesn't mean that the company can't give updates before then.
(127)
•••
mingzhu
X
View Profile
View Bullboard History
Post by
mingzhu
on Dec 16, 2020 4:25pm
how long is the P3 trial?
eom
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Dec 16, 2020 12:44pm
RE:RE:RE:Bid/Ask is looking healthier !!!
By my calculations, the discrepancy between the value in OncoQuest (South Korea) alone and our share price is extreme. At some point it has to correct - that's why I was buying. Will we see some
...more
(97)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Dec 16, 2020 10:25am
RE:RE:Bid/Ask is looking healthier !!!
This is a surprize. I don't see any news this morning. Nice gap up. Nive volume 400K+. Tax loss sellers getting back in the game?? G1945V
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Dec 16, 2020 10:14am
RE:Bid/Ask is looking healthier !!!
Dec 16 10:11:41 AM 0.25 12 NBDLT 62 79 Dec 16 10:11:41 AM 0.25 49500 89 79
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company